Alzheimer's drug Namenda receives patent extension

Share this content:
The patent term for Namenda has been extended through April 10, 2015, according to Forest Laboratories. The medication is used to help treat people with Alzheimer's disease. The patent had earlier been set to expire on Sept. 13, 2013. Namenda sales hit $240.9 million in the third quarter, according to the firm

Next Article in Products